Fesoterodine Fumarate | Market Exclusivity | US | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Fesoterodine Fumarate
U.S. EXCLUSIVITIES

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Contact Supplier

Jai Radhe Sales is your partner for all your sourcing needs.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

Contact Supplier

Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Fesoterodine Fumarate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

24 API Suppliers, 15 USDMF, 6 EU WC, 5 KDMF, 7 NDC API, 13 Listed Suppliers, $ API Reference Price

24 API Suppliers
15 USDMF
6 EU WC
5 KDMF
7 NDC API
13 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

INTERMEDIATES

4 Intermediates Suppliers

4 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

93 FDF Dossiers, 30 FDA Orange Book, 45 Europe, 4 Canada, 14 Listed Dossiers

93 FDF Dossiers
30 FDA Orange Book
45 Europe
4 Canada
14 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - 4MG, TABLET, EXTENDED RELEASE;ORAL - 8MG

TABLET, EXTENDED RELEASE;ORAL - 4MG
TABLET, EXTENDED RELEASE;ORAL - 8MG

RELATED EXCIPIENT COMPANIES

2 Rochem International Inc, 4 SPI Pharma, 2 Seqens, 4 DKSH, 1 Pharm-RX Chemical, 4 Faran Shimi Pharmaceutical, 1 Boai NKY Pharmaceuticals Ltd, 11 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 4 Actylis, 1 Aeon Procare, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 18 BASF, 10 Corel Pharma Chem, 4 DFE Pharma, 1 Finar, 7 Gangwal Chemicals, 7 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 31 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 11 Microlex e.U, 2 Nomisma Healthcare, 3 Novo Excipients, 2 Pharmatrans-Sanaq, 4 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 15 Roquette, 7 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 2 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

64 Fillers, Diluents & Binders, 51 Coating Systems & Additives, 32 Controlled & Modified Release, 29 Direct Compression, 20 Thickeners and Stabilizers, 17 Granulation, 14 Co-Processed Excipients, 13 Solubilizers, 13 Disintegrants & Superdisintegrants, 12 Lubricants & Glidants, 11 Topical, 9 Taste Masking, 8 Film Formers & Plasticizers, 7 Chewable & Orodispersible Aids, 7 Parenteral, 5 Empty Capsules, 5 API Stability Enhancers, 4 Coloring Agents, 4 Rheology Modifiers, 4 Vegetarian Capsules, 3 Emulsifying Agents

64 Fillers, Diluents & Binders
51 Coating Systems & Additives
32 Controlled & Modified Release
29 Direct Compression
20 Thickeners and Stabilizers
17 Granulation
14 Co-Processed Excipients
13 Solubilizers
13 Disintegrants & Superdisintegrants
12 Lubricants & Glidants
11 Topical
9 Taste Masking
8 Film Formers & Plasticizers
7 Chewable & Orodispersible Aids
7 Parenteral
5 Empty Capsules
5 API Stability Enhancers
4 Coloring Agents
4 Rheology Modifiers
4 Vegetarian Capsules
3 Emulsifying Agents

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 21 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
21 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 45 Finished Drug Prices, 9 Annual Reports

1 US Medicaid Prescriptions
45 Finished Drug Prices
9 Annual Reports

MARKET PLACE

3 APIs, 1 Intermediates

3 APIs
1 Intermediates

PATENTS & EXCLUSIVITIES

12 US Patents, 4 US Exclusivities, 8 Health Canada Patents

12 US Patents
4 US Exclusivities
8 Health Canada Patents

$ API Ref.Price (USD/KG) : 6,039 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

4 All

01 4PFIZER

filter Product Reset all filters

4 All

01 4FESOTERODINE FUMARATE

filter Exclusivity Expiration Date Reset all filters

4 All

01 22024-06-17

02 22024-12-17

filter Exclusivity Code Reset all filters

4 All

01 2I-861

02 2PED

Product Main Page

PFIZER

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

FESOTERODINE FUMARATE

Portfolio PDF

Product Web Link

Digital Content

Exclusivity Code

PED

Exclusivity Expiration Date

2024-12-17

Application Number

22030

Product Number

2

Exclusivity Details

01

PFIZER

FESOTERODINE FUMARATE

CPhI India 2024

Not Confirmed

PFIZER

U.S.A

CPhI India 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

FESOTERODINE FUMARATE

Exclusivity Code : PED

Exclusivity Expiration Date : 2024-12-17

Application Number : 22030

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

PFIZER

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

FESOTERODINE FUMARATE

Portfolio PDF

Product Web Link

Digital Content

Exclusivity Code

PED

Exclusivity Expiration Date

2024-12-17

Application Number

22030

Product Number

1

Exclusivity Details

02

PFIZER

FESOTERODINE FUMARATE

CPhI India 2024

Not Confirmed

PFIZER

U.S.A

CPhI India 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

FESOTERODINE FUMARATE

Exclusivity Code : PED

Exclusivity Expiration Date : 2024-12-17

Application Number : 22030

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

PFIZER

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

FESOTERODINE FUMARATE

Portfolio PDF

Product Web Link

Digital Content

Exclusivity Code

I-861

Exclusivity Expiration Date

2024-06-17

Application Number

22030

Product Number

2

Exclusivity Details

03

PFIZER

FESOTERODINE FUMARATE

CPhI India 2024

Not Confirmed

PFIZER

U.S.A

CPhI India 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

FESOTERODINE FUMARATE

Exclusivity Code : I-861

Exclusivity Expiration Date : 2024-06-17

Application Number : 22030

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

PFIZER

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

FESOTERODINE FUMARATE

Portfolio PDF

Product Web Link

Digital Content

Exclusivity Code

I-861

Exclusivity Expiration Date

2024-06-17

Application Number

22030

Product Number

1

Exclusivity Details

04

PFIZER

FESOTERODINE FUMARATE

CPhI India 2024

Not Confirmed

PFIZER

U.S.A

CPhI India 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

FESOTERODINE FUMARATE

Exclusivity Code : I-861

Exclusivity Expiration Date : 2024-06-17

Application Number : 22030

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?